Company: MYSEW
Filing Date: 2025-02-10
Form Type: 424B5
Source: 0001213900-25-011767
Chunk: 23

Company: Myseum, Inc.
Filing Date: 2025-02-10
Form: 424B5
Chunk 23
---
 if sales of common stock sold through Benchmark pursuant to the Sales Agreement exceeds $1,000,000
then the commission paid to Benchmark will be reduced to 3.0% of the aggregate gross proceeds we receive from each sale of our common
stock sold through Benchmark pursuant to the Sales Agreement. Because there is no minimum offering amount required as a condition to close
this offering, the actual total public offering amount, Benchmark’s commissions and the proceeds to us, if any, are not determinable
at this time. We have also agreed to reimburse Benchmark for certain reasonable and documented expenses, including fees and disbursements
of its counsel, up to an amount of $25,000. We estimate that the total expenses of the offering payable by us, excluding any commissions
and the reimbursement payable to Benchmark under the terms of the Sales Agreement, will be approximately $57,500. The remaining sale proceeds,
after deducting any other transaction fees, will equal the net proceeds from the sale of such common stock.

Benchmark will provide written
confirmation to us before the open on Nasdaq on the day following each day on which our shares of common stock are sold under the Sales
Agreement. Each confirmation will include the number of shares sold on that day, the aggregate gross proceeds of such sales and the net
proceeds.

In connection with the sale
of common stock on our behalf, Benchmark will be deemed to be an “underwriter” within the meaning of the Securities Act, and
the compensation of Benchmark will be deemed to be underwriting commissions or discounts. We have agreed to provide indemnification and
contribution to Benchmark against certain liabilities, including liabilities under the Securities Act.

The offering of our common
stock pursuant to the Sales Agreement will terminate upon the earlier of (i) the issuance and sale of all shares of our common stock subject
to the Sales Agreement; and (ii) the termination of the Sales Agreement as permitted therein. We or Benchmark may suspend the offering
of common stock under the Sales Agreement upon proper notice to the other party and subject to other conditions.

This summary of the material provisions of the Sales Agreement does not purport to be a complete statement of its terms and conditions
and is qualified in its entirety to such, a copy of which will be attached as an exhibit to our Current Report on Form 8-K being filed
with the SEC in connection with this offering.

Benchmark and its affiliates
may in the future provide various investment banking and other financial services for us and our affiliates, for